Skip to content
HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
It is true that natural infection almost always causes better immunity than vaccines. Whereas immunity from disease often follows a single natural infection, immunity from vaccines usually occurs only after several doses. However, the difference between vaccination and natural infection is the price paid for immunity.
The price paid for immunity after natural infection might be pneumonia from chickenpox, intellectual disability from Haemophilus influenzae type b (Hib), pneumonia from pneumococcus, birth defects from rubella, liver cancer from hepatitis B virus, or death from measles.
Immunization with vaccines, like natural infections, induces long-lived immunity. But unlike natural infection, immunization does not extract such a high price for immunity.
If you could see the world from the perspective of your immune system, you would realize that where the virus or bacteria comes from is irrelevant. Your immune system “sees” something that is foreign, attacks it, disables it and then adds it to the memory bank so it can react more quickly the next time it encounters it.
The differences between a vaccine and getting the disease naturally are the dose and the known time of exposure.
Of interest, a few vaccines induce a better immune response than natural infection:
So, in summary, vaccines afford us protection with lesser quantities of virus or bacteria and the control of scheduling the exposure.
Listen to Dr. Offit explain natural infection and vaccination by watching this short video, part of the Talking About Vaccines with Dr. Paul Offit video series.
View this video with a transcript
Many of today’s consumers crave organic, all-natural, or free-range products. Willing to pay more and drive further to get these products, they believe they are keeping their families healthy. Some of these same people forego vaccines claiming that they are not natural.
According to the Merriam-Webster dictionary, natural means “being in accordance with or determined by nature.” Viruses and bacteria are natural; diseases caused by them are natural.
Because vaccines are made using parts of the viruses and bacteria that cause disease, the ingredient that is the active component of the vaccine that induces immunity is natural. However, critics point to other ingredients in vaccines or the route of administration as being unnatural.
“Green our vaccines” is a common mantra of those who believe that the ingredients in vaccines are harmful and unnatural. However, vaccine vials contain well-characterized ingredients in known quantities.
Vaccines contain three types of ingredients other than the virus or bacterium of interest:
Some wonder about the amount of different additives in vaccines or the cumulative effect from several vaccines. This is a valid concern; in fact, the Swiss chemist Paracelsus coined the phrase, “the dose makes the poison.” However, the good news is that the quantities of ingredients in vaccines are determined to be the lowest amounts necessary and when vaccines are given together, they must be studied together. So the quantities of ingredients in vaccines have been determined to be safe.
Viruses and bacteria typically enter the body through our noses or mouths. With the exception of the oral rotavirus vaccine, most vaccines are given as a shot. While at first glance the injections appear to be different or “unnatural,” they are not when you consider what happens in each case.
When viruses or bacteria enter the body through the nose or mouth, they are detected by cells of the immune system that line the surfaces of these areas of entry. These “foreign invaders” are ingested by immune cells and processed in lymph nodes in the region of the infection. The immune response has two aspects, local and systemic. The immune cells are produced near the site of the infection, but they are dispersed throughout the body via the bloodstream. After the infection has been resolved, a small number of immune memory cells continue circulating to monitor for future infections. Because these memory responses are specific, subsequent exposures to the same virus or bacterium generate a quicker and stronger immune response that completely prevents or significantly lessens the effects and duration of illness.
Vaccines are no different. Although common belief is that vaccines are injected directly into the bloodstream, they are actually administered into muscle or the layer of skin below the dermis where immune cells are produced and circulate as occurs following natural infection.
The active ingredients in vaccines are the parts of the viruses or bacteria to which we make an immune response. The additional ingredients are determined to be the lowest plausible quantities and are studied as part of the vaccine during safety testing. The immune system responds in the same way it would to the virus or bacteria following unexpected introduction. So while not natural in that they are given at specified times, vaccines offer a controlled way to protect ourselves from the viruses or bacteria that cause illness.
The short answer to this question is no. Let’s take the example of a nosode to prevent human papillomavirus (HPV). The nosode is made by first taking fluid from the cervix of a woman infected with HPV. The fluid is then diluted to the point that no HPV is present. Therefore, a nosode is composed only of the fluid that was used to dilute the virus. For this reason, an HPV nosode cannot possibly prevent HPV infection.
A nosode vaccine is made using the concept of homeopathy, which was first introduced by Dr. Samuel Hahnemann. Proponents of homeopathy believe that while, in this case, HPV is no longer present in the nosode, the solution maintains a “memory” of the original agent that protects the patient from subsequent infection. No evidence supports this notion. And, quite frankly, it’s a good thing that the original HPV is no longer present. Otherwise, the recipient would be at risk of catching the virus.
Real vaccines, on the other hand (like the HPV vaccine), are made with known, measureable quantities of killed pathogens or individual pieces of them, such as proteins or inactivated toxins. Likewise, measurable immune responses are generated. In contrast, nosodes are made from solutions that have been randomly diluted (different providers dilute the materials differently) such that no measurable material remains. Because no infectious materials remains, measurable immune responses are not generated.
In July 2015, the Canadian Minister of Health required changes to labelling of nosodes. Beginning in January 2016, any nosodes must include the following statement: “This product is neither a vaccine nor an alternative to vaccination. This product has not been proven to prevent infection. Health Canada does not recommend its use in children and advises that your child receive all routine vaccinations.”
Studies on the diversity of antibody specificities indicate that the immune system has the capacity to respond to extremely large numbers of immunologically distinct regions of viruses and bacteria. Current data suggest that the theoretical capacity determined by the genes that make different antibodies would allow for as many as 109-1011 different kinds of antibodies (i.e., 1 billion to 100 billion). But this theoretical capacity is limited by the number of circulating antibody-producing cells (B cells or lymphocytes) and the likely redundancy of antibodies generated by one individual.
A more practical way to determine the diversity of the immune response would be to estimate the number of vaccines to which a child could respond at one time. Assuming the quantities of antibodies likely generated by an individual in 1 ml of blood (one-fifth of a teaspoon) during seven days after exposure to a vaccine, and the number of different specificities of those antibodies, then each infant would have the capacity to respond to about 10,000 vaccines at any one time. Using this estimate, one would predict that if 11 vaccines were given to infants at one time, then about 0.1 percent of the immune system would be "used up."
However, because B cells and other lymphocytes are constantly replenished, a vaccine never really "uses up" a fraction of the immune system. For example, the immune system has the ability to replenish about 2 billion lymphocytes each day. This replacement activity illustrates the enormous capacity of the immune system to generate lymphocytes as needed.
Parents may also take comfort in knowing that children are exposed to fewer immunologic components (like proteins and sugars [polysaccharides]) in vaccines today than in the past. The table below summarizes the number of proteins and polysaccharides contained in routinely recommended vaccines administered during the past 100 years. Although we now give children more vaccines, the actual number of immunologic components in vaccines has declined.
Whereas previously one vaccine, smallpox, contained about 200 proteins, now the 14* routinely recommended vaccines contain about 160 immunologic components (i.e., proteins or polysaccharides). Two factors account for this decline: first, the worldwide eradication of smallpox obviated the need for that vaccine, and second, advances in protein chemistry have resulted in vaccines containing fewer antigens (e.g. replacement of whole-cell with acellular pertussis vaccine).
*Infants and young children receive vaccines to prevent 14 different diseases; some are given in combination.
Adapted from: Offit PA, et al. Addressing parents' concerns: Do vaccines weaken or overwhelm the infant's immune system? Pediatrics 2002;109:124-129.
Learn more about concerns surrounding the number of vaccines by watching this short video, part of the Talking About Vaccines with Dr. Paul Offit video series.
Vaccinated children are not at greater risk of other infections (infections not prevented by the vaccines) than unvaccinated children. On the contrary, in Germany, a study of 496 vaccinated and unvaccinated children found that children who received immunizations against diphtheria, pertussis, tetanus, Haemophilus influenzae type b (Hib) and polio within the first three months of life had fewer infections with vaccine-related and unrelated pathogens than the non-vaccinated group.
Bacterial and viral infections, on the other hand, often predispose children and adults to severe, invasive infections with other pathogens. For example, children with pneumococcal pneumonia are more likely to have had a recent influenza infection than other children. Similarly, varicella infection increases susceptibility to the 'flesh-eating bacteria (i.e., group A strep).
Some parents may be concerned that children with acute illnesses are less likely to respond to vaccines or are more likely to develop severe reactions to vaccines than are healthy children. Alternatively, some parents may believe that children who are ill shouldn't further burden an immune system already committed to fighting an infection. However, vaccine-specific antibody responses and rates of vaccine-associated adverse reactions of children with mild or moderate illnesses are comparable to those of healthy children. For example, the presence of upper respiratory tract infections, ear infections, fever, skin infections or diarrhea does not affect the level of protective antibodies induced by immunization.
Data on the capacity of vaccines to induce protective immune responses in children with severe infections (such as those with bacterial pneumonia or meningitis) are lacking. Although a delay in vaccines is recommended for children with severe illnesses until the symptoms of illness resolve, this recommendation is not based on the likelihood that the child will have an inadequate immune response to the vaccine. Rather, the reason for deferring immunization is to avoid superimposing a reaction to the vaccine on the underlying illness or to mistakenly attribute a manifestation of the underlying illness to the vaccine.
No. If children are not too young to be permanently harmed or killed by viruses or bacteria, they aren't too young to be vaccinated to prevent those diseases. Because the diseases that vaccines prevent often occur in very young infants, the only way to prevent them is to give vaccines soon after birth. Fortunately, infants given vaccines in the first few months of life are quite capable of making a protective immune response.
Watch a video clip about whether children are too young to get vaccines.
The mother's womb is essentially a sterile environment. The fluid surrounding the baby is free from bacteria. However, within minutes of leaving the womb, the child must confront thousands of bacteria. By the end of the first week of life, the child's skin, nose, throat and intestines are covered with tens of thousands of different bacteria.
Fortunately, from the moment of birth, infants begin to develop an active immune response to these bacteria — an immune response that prevents these bacteria from entering the bloodstream and causing harm.
The vaccines that children receive in the first two years of life are just a drop in the ocean when compared with the tens of thousands of environmental challenges that babies successfully manage every day.
Watch a video clip about getting multiple vaccines at one time.
Glanz JM, Newcomer SR, Daley MF, DeStefano F, et al. Association between estimated cumulative vaccine antigen exposure through the first 23 months of life and non-vaccine-targeted infections from 24 through 47 months of age. JAMA 2018;319(9):906-913.
The authors determined the relationship between the number of vaccines given in the first two years of life and the occurrence of non-vaccine targeted infections between two and four years of age. They found no difference in either the cumulative number of antigens or the number of antigens received in a single day in children who developed non-vaccine targeted infections.
Sherrid AM, Ruck CE, Sutherland D, et al. Lack of broad functional differences in immunity in fully vaccinated vs. unvaccinated children. Pediatr Res 2017;81(4):601-608.
The authors assessed the immune response to general, non-vaccine specific stimuli in fully vaccinated and entirely unvaccinated children between 3 and 5 years of age. They found that standard childhood vaccines did not cause long-lasting, gross alterations of the immune system.
DeStefano F, Price CS, Weintraub ES. Increasing exposure to antibody-stimulating proteins and polysaccharides in vaccines is not associated with risk of autism. J Pediatr 2013;163:561-567.
The authors evaluated the relationship between the total cumulative vaccine-specific antigen exposure or maximum exposure on a single day and the development of autism spectrum disorder (ASD), autistic disorder (AD) or ASD with regression. They found no association between antigen exposure from vaccines during the first two years of life and the risk of developing ASD, AD, or ASD with regression.
Iqbal S, Barile JP, Thompson WW, DeStefano F. Number of antigens in early childhood vaccines and neuropsychological outcomes at age 7-10 years. Pharmacoepidemiol Drug Saf 2013;22:1263-1270.
The authors compared neuropsychological outcomes in more than 1,000 children aged 7-10 years with the number of vaccine-specific antigens to which they were exposed during the first 24 months of life. They found no correlation between the number of vaccine-specific antigens received and adverse neuropsychological outcomes.
Smith MJ and Woods CR. On-time vaccine receipt in the first year does not adversely affect neuropsychological outcomes. Pediatrics 2010;125;1134-1141.
The authors compared long-term neuropsychological outcomes in children who received vaccines on time with those with delayed or incomplete vaccination during infancy. Timely vaccination was not associated with adverse neuropsychological outcomes 7 to 10 years later. The authors concluded that there was no benefit in delaying immunizations during the first year of life.
Hviid A, Wohlfahrt J, Stellfeld M, et al. Childhood vaccination and nontargeted infectious disease hospitalization. JAMA 2005;294(6):699-705.
The authors evaluated the relationship between routinely administered childhood vaccines and the occurrence of non-targeted infectious diseases in more than 800,000 children. They found that neither the number of vaccines nor the receipt of multiple-antigen vaccines increased the risk of hospitalizations caused by non-targeted infectious diseases.
Offit PA, Quarles J, Gerber MA, et al. Addressing parents’ concerns: do multiple vaccines overwhelm or weaken the infant’s immune system? Pediatrics 2002;109(1):124-129.
Given the number of antibody-generating B cells in the circulation, the number of vaccine-specific antigens to which infants are exposed during the first few years of life, and the quantity of antibodies necessary to react to each antigen, the authors estimated that infants have the theoretical capacity to respond to at least 10,000 vaccines at one time. The authors also showed that the number of immunological components in current vaccines is actually less than the one vaccine (smallpox) that children received 100 years ago.
Materials in this section are updated as new information and vaccines become available. The Vaccine Education Center staff regularly reviews materials for accuracy.
You should not consider the information in this site to be specific, professional medical advice for your personal health or for your family's personal health. You should not use it to replace any relationship with a physician or other qualified healthcare professional. For medical concerns, including decisions about vaccinations, medications and other treatments, you should always consult your physician or, in serious cases, seek immediate assistance from emergency personnel.